Oxford

The Oxford Branch studies signaling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment.

About

Ludwig Oxford approaches the problems of cancer biology from several different angles. Our research program explores cancer susceptibility, initiation, progression, metastasis and resistance to therapy, and includes technical expertise essential to the development of novel clinical and research technologies—such as computational modeling and chemical biology. Over all, our specific areas of interest include the study of tumor heterogeneity and the regulation of gene expression, reflecting our interests in genetics, epigenetics, the tumor microenvironment, cell signaling and gene expression. Our branch has recently launched a multidisciplinary research program focused on upper gastrointestinal cancers, with the aim of developing novel approaches to preventing, diagnosing and treating such malignancies. Our laboratories are housed in the Old Road Campus Research Building, and we are affiliated with the Nuffield Department of Medicine at the University of Oxford.

DIRECTOR

Principal Investigators

Adjuncts

Highlights

News

November 30, 2020
August 12, 2019
January 8, 2019
More News

Careers

Postdoctoral Researcher in Methyltransferases
Deadline: December 16, 2020
See More

Postdoctoral Researcher in Methyltransferases

Nuffield Department of Medicine (NDM), Ludwig Institute for Cancer Research and Oxford Big Data Institute, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, UK.

Grade 7: Salary in range £32,817 – £40,322 per annum

Only online applications received by 12:00 noon (UK time), December 16, 2020, will be considered.

The Ludwig Institute for Cancer Research, Oxford Branch, is seeking a Postdoctoral Research Scientist in Methyltransferases to join Professor Yang Shi’s research group to investigate newly identified RNA m6A methyltransferases. This is an exciting opportunity to join a leading cancer research institute.

As Postdoctoral Research Scientist in Methyltransferases, you will investigate newly identified RNA m6A methyltransferases using biochemical, molecular and genetic approaches to study their functions and mechanisms of action in both cell lines and model organisms. You will manage your own academic research and administrative activities, including small-scale project management, and coordinate multiple aspects of work to meet deadlines. You will use your expertise to supervise and train junior staff in chromatin and cancer biology. You will interpret results and present them to senior members of the group and Professor Shi. You will communicate with Professor Shi and other members of the group as required, ensuring that they are kept fully up to date with progress and any difficulties in the research project. You will work towards publishing your findings in international journals and representing the group at meetings.

Applicants must have a PhD in a relevant field and previous laboratory experience relevant to the project, as well as significant background in RNA biochemistry. The successful candidate will have a strong publication record for career stage, such as first-author publications in internationally recognized journals, a demonstrated attention to detail and excellent written and verbal communication skills.

This post is fixed term for 3 years and is funded by the Ludwig Institute for Cancer Research.

Applications must be made online by 12:00 noon (UK time), December 16, 2020.

See Full Job Posting    

Postdoctoral Research Scientist – Cancer Immunology (two posts)
Deadline: January 6, 2021
See More

Postdoctoral Research Scientist – Cancer Immunology (two posts)

 Nuffield Department of Medicine (NDM), Ludwig Institute for Cancer Research and Oxford Big Data Institute, Old Road Campus Research Building, Roosevelt Drive, Headington, Oxford, UK.

Grade 7: Salary in range £32,817 – £40,322 per annum (with discretionary range to £44,045)

Only online applications received by 12:00 noon (UK time), January 6, 2021, will be considered.

The Ludwig Institute for Cancer Research is seeks two Postdoctoral Research Scientists in Cancer Immunology to join Yang Shi’s research group at the Oxford Branch. Working in collaboration with Benoit Van den Eynde’s group, the postdoc will investigate the effects of epigenetic mechanisms on immune checkpoint therapy using chromatin biology, biochemistry and epigenomics technologies.

As a Postdoctoral Research Scientist in Cancer Immunology, you will perform and manage your own academic research and administrative activities, including small scale project management and the coordination of multiple aspects of work to meet deadlines. Using your expertise, you will supervise and train junior staff in chromatin and cancer biology.

Applicants must have a PhD (or be close to completion of doctoral studies) in immunology or a relevant field, and have previous laboratory experience relevant to the project, as well as a significant background in immunology/cancer immunology. It is essential that applicants have a strong publication record for career stage, such as first-author publications in internationally recognised journals, and a demnstrted attention to detail. Applicants are also expected to have excellent written and verbal communication skills.

This post is fixed term for 3 years and is funded by the Ludwig Institute for Cancer Research.

Applications must be made online by 12:00 noon (UK time) on Wednesday, January 6, 2021.

 

See Full Job Posting    

   Back to Locations

Ludwig Institute for Cancer Research, Oxford
Nuffield Department of Clinical Medicine
Old Road Campus Research Building
off Roosevelt Drive, Headington, Oxford, OX3 7DQ, UK

T +44 (0) 1865 617507

Notice
?

You are now leaving Ludwig Cancer Research's website and are going to a website that is not operated by the association. We are not responsible for the content or availability of linked sites. Do you wish to continue?

Continue
Cancel